Metlife (MET-PA) Current Deferred Revenue (2020 - 2026)

Metlife's Current Deferred Revenue history runs 7 years deep, the most recent figure standing at $5.2 billion for Q1 2026.

• In Q1 2026, Current Deferred Revenue rose 9.51% year-over-year to $5.2 billion; the TTM figure through Mar 2026 stood at $5.2 billion (up 9.51% YoY), while the FY2025 annual figure was $5.2 billion, up 11.37% from the prior year.
• Current Deferred Revenue was $5.2 billion for Q1 2026 at Metlife, roughly flat from $5.2 billion in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $5.2 billion in Q1 2026 to a low of $3.8 billion in Q1 2022.
• Historically, Current Deferred Revenue has averaged $4.5 billion across 5 years, with a median of $4.6 billion in 2024.
• The sharpest annual moves came in 2023 and 2024: Current Deferred Revenue increased 17.22% in 2023, then grew 2.16% in 2024.
• A 5-year view of Current Deferred Revenue shows it stood at $4.1 billion in 2022, then rose by 10.5% to $4.5 billion in 2023, then climbed by 2.16% to $4.6 billion in 2024, then grew by 11.37% to $5.2 billion in 2025, then gained by 0.43% to $5.2 billion in 2026.
• The last three Current Deferred Revenue figures came in at $5.2 billion (Q1 2026), $5.2 billion (Q4 2025), and $5.1 billion (Q3 2025), per Business Quant data.